Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 6
Author(s): Christian C. Felder
Affiliation:
Export Options
About this article
Cite this article as:
Felder C. Christian , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (6) . https://dx.doi.org/10.2174/1570159X1706190423093749
DOI https://dx.doi.org/10.2174/1570159X1706190423093749 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
40
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Regulation of Neural Stem Cells in the Human SVZ by Trophic and Morphogenic Factors
Current Signal Transduction Therapy The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Current Cancer Drug Targets Nerve Conduction Through Dendrites via Proton Hopping
Current Computer-Aided Drug Design Editorial:
Current Immunology Reviews (Discontinued) Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions
Current Drug Metabolism Disequilibrium and Risk of Falling in the Elderly is a Priority for Health Services
Reviews on Recent Clinical Trials Meet Our Editorial Board Member
Current Neuropharmacology LECTURES
Adolescent Psychiatry Impact of COVID-19 on Indian Pharmaceutical Industry and Way Forward
Infectious Disorders - Drug Targets Notoginsenoside R1 Promotes the Growth of Neonatal Rat Cortical Neurons via the Wnt/β-catenin Signaling Pathway
CNS & Neurological Disorders - Drug Targets Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Current Medicinal Chemistry Gene Expression Profiles in Human Autoimmune Disease
Current Pharmaceutical Design A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
Current Neuropharmacology Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
Recent Patents on CNS Drug Discovery (Discontinued) Molecular Dynamics Simulations of Intrinsically Disordered Proteins in Human Diseases
Current Computer-Aided Drug Design Acamprosate: How, Where, and for Whom Does it Work? Mechanism of Action, Treatment Targets, and Individualized Therapy
Current Pharmaceutical Design Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead
Current Diabetes Reviews Alcohol Addiction: A Molecular Biology Perspective
Current Medicinal Chemistry Cannabinoid Receptors as Therapeutic Targets
Current Pharmaceutical Design Towards an Understanding of the Anti-Aging Mechanism of Caloric Restriction
Current Aging Science